A new way to regulate protein levels and functions could be the answer to treating devastating neurological conditions
New details learned about a key cellular protein could lead to treatments for neurodegenerative diseases, such as Parkinson’s, Huntington’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS).
At their root, these disorders are triggered by misbehaving proteins in the brain. The proteins misfold and accumulate in neurons, inflicting damage and eventually killing the cells. In a new study, researchers in the laboratory of Steven Finkbeiner, MD, PhD, at the Gladstone Institutes used a different protein, Nrf2, to restore levels of the disease-causing proteins to a normal, healthy range, thereby preventing cell death.
The researchers tested Nrf2 in two models of Parkinson’s disease: cells with mutations in the proteins LRRK2 and a-synuclein. By activating Nrf2, the researchers turned on several “house-cleaning” mechanisms in the cell to remove excess LRRK2 and a-synuclein.
“Nrf2 coordinates a whole program of gene expression, but we didn’t know how important it was for regulating protein levels until now,” explained first author Gaia Skibinski, PhD, a staff research scientist at Gladstone. “Overexpressing Nrf2 in cellular models of Parkinson’s disease resulted in a huge effect. In fact, it protects cells against the disease better than anything else we’ve found.”
In the study, published in the Proceedings of the National Academy of Sciences, the scientists used both rat neurons and human neurons created from induced pluripotent stem cells. They then programmed the neurons to express Nrf2 and either mutant LRRK2 or a-synuclein. Using a one-of-a-kind robotic microscope developed by the Finkbeiner laboratory, the researchers tagged and tracked individual neurons over time to monitor their protein levels and overall health. They took thousands of images of the cells over the course of a week, measuring the development and demise of each one.
The scientists discovered that Nrf2 worked in different ways to help remove either mutant LRRK2 or a-synuclein from the cells. For mutant LRRK2, Nrf2 drove the protein to gather into incidental clumps that can remain in the cell without damaging it. For a-synuclein, Nrf2 accelerated the breakdown and clearance of the protein, reducing its levels in the cell.
“I am very enthusiastic about this strategy for treating neurodegenerative diseases,” said Finkbeiner, a senior investigator at Gladstone and senior author on the paper. “We’ve tested Nrf2 in models of Huntington’s disease, Parkinson’s disease, and ALS, and it is the most protective thing we’ve ever found. Based on the magnitude and the breadth of the effect, we really want to understand Nrf2 and its role in protein regulation better.”
The scientists say that Nrf2 itself may be difficult to target with a drug because it is involved in so many cellular processes, so they are now focusing on some of its downstream effects. They hope to identify other players in the protein regulation pathway that interact with Nrf2 to improve cell health and that may be easier to drug.
Receive an email update when we add a new NEURODEGENERATIVE DISEASES article.
The Latest on: Regulate protein levels and functions
via Google News
The Latest on: Regulate protein levels and functions
- Stoichiometric optimization of Gata4, Hand2, Mef2c, and Tbx5 expression for contractile cardiomyocyte reprogrammingon October 18, 2019 at 2:15 am
Transduction of the quad-cistronic vector with a splicing order of M-G-T-H (referred to as M-G-T-H) inducing relatively low Hand2 and high Mef2c protein levels not only increased sarcomeric protein ...
- Sphingosine 1-phosphate: Lipid signaling in pathology and therapyon October 17, 2019 at 12:06 pm
Sphingosine 1-phosphate (S1P), a metabolic product of cell membrane sphingolipids, is bound to extracellular chaperones, is enriched in circulatory fluids, and binds to G protein–coupled S1P receptors ...
- New insights into the structure and function of Cdc34, a target for cancer therapeuticson October 17, 2019 at 10:15 am
It included biochemists who study how the body's proteins function at a molecular level, and cancer biologists and clinicians who could extend ... Cdc34 is a central player in a cascade of E1-3 ...
- Team identifies a protein that helps regulate blood glucose and lipidson October 17, 2019 at 6:27 am
In order to improve therapy, researchers at the University of Geneva (UNIGE), Switzerland, have identified a protein called S100A9 ... i.e. a drop in blood glucose levels that can lead to coma or even ...
- MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4)on October 17, 2019 at 5:26 am
This study was designed to investigate the mechanism by which miR-129-5p affects the biological function of liver cancer cells ... the results also demonstrated that the phosphorylation levels of ERK1 ...
- Researchers identify circuit that links cigarette smoking and risk of developing diabeteson October 16, 2019 at 1:05 pm
The nicotine activates nicotine acetylcholine receptor (nAChR) proteins expressed on neurons in the medial habenula (a brain area that regulates aversive reactions ... pancreas and liver that ...
- Study shows how electrostatic interactions can be regulated to control scroll-like cochleate structureson October 15, 2019 at 10:19 pm
Charged molecules, such as DNA and proteins, are present throughout biological systems ... "Understanding the transition mechanisms will allow for greater control over forms -- and thus the function - ...
- Study reveals limitations of method for determining protein structureon October 15, 2019 at 5:00 pm
Membrane proteins are critically important because they regulate the exchange of information and materials between the cell and its environment, a vital task for survival and normal function of the ...
- IBD and Infection Control Linked with Disruption to Gut Immune Cell Clock Geneson October 7, 2019 at 6:25 am
Wang and Colonna reasoned that reductions in ILC3 cell numbers or changes in ILC3 function could affect the body’s ability to fight intestinal infections. Subsequent studies showed that in comparison ...
via Bing News